Clinical Trial Update: Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)

View source ↗

Summary

This completed clinical trial evaluated whether insulin resistance affects the safety and efficacy of pegylated interferon plus ribavirin therapy in chronic hep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Hepatitis C Virus | Status: COMPLETED | Results posted: 2011-09-16